 |
인쇄하기
취소
|
LG Life Science to export Factive technology to Japan.
LG Life Science sold the Factive technology to aRigen, Japanese company. Factive is a derivative of the quinolone antibiotic drugs exclusively developed by LG Life Science.
The technology sale revealed a front payment of U$2 million including a milestone payment and a certain rate of revolving royalty on the net sales for 10 years after its market launching.
The company said "By this occa...
The technology sale revealed a front payment of U$2 million including a milestone payment and a certain rate of revolving royalty on the net sales for 10 years after its market launching.
The company said "By this occa...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.